VTE PREVENTION UPDATE, WA (May 2010) Dr Helen van Gessel Office of Safety and Quality Luke SlawomirskiPerformance Activity & Quality Division Delivering.

Slides:



Advertisements
Similar presentations
IMPROVING THE MANAGEMENT OF LONG TERM CONDITIONS AIMS 1For me to share with you –What weve learned so far –What we dont know yet 2 Your help to develop.
Advertisements

Diabetic Foot Problems
Copyright © 2012 Siemens Medical Solutions USA, Inc. All rights reserved. Innovations ‘11 A914CX-HS C1-4A00.
Preventable Hospitalizations: Assessing Access and the Performance of Local Safety Net Presented by Yu Fang (Frances) Lee Feb. 9 th, 2007.
The national medication chart A summary of the 2012 changes NATIONAL MEDICATION SAFETY PROGRAMME.
Changes to Performance-Based Payment Programs
Venous Thromboembolism Prevention August Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for.
Venous Thromboembolism (VTE) Prophylaxis Policy Mary-Anne Davies Patient Safety Specialist Accreditation Coordinator.
The Health Roundtable 3-3c_HRT1215-Session_HANNAFORD_UNSW_NSW How many people received appropriate VTE prophylaxis? Presenter: Natalie Hannaford UNSW Innovation.
Development and Testing of a Risk Assessment Model for Venous Thrombosis in Medical Inpatients: The Medical Inpatients and Thrombosis (MITH) Study Score.
CMS Core Measures Evidence-Based Performance Measurement.
 When untreated, general postsurgical patients risk for Deep Venous Thrombosis (DVT) is 19%-25% (Buckner, et al., 2013).  Post surgical orthopedic patients.
Chapter 15 Newborn (Perinatal) Guidelines ( )
Medication Reconciliation in WA Luke Slawomirski Office of Safety and Quality in Healthcare Delivering a Healthy WA.
Overview of services provided in Fareham and Gosport by Southern Health NHS Foundation Trust Fareham and Gosport Voluntary Sector Health Forum May 2015.
What is happening in Neurology? Orla Hardiman MD,FRCPI, FAAN Director of Neurology Beaumont Hospital.
AHRQ Quality Indicators Toolkit Tool A.2 Instructions.
Cost-Conscious Care Presentation Follow-up Chest X-Ray in Patients Admitted for Community Acquired Pneumonia Huy Tran, PGY-2 12/12/2013.
Patient Safety and Public Health Informatics Iona Thraen, ACSW Patient Safety Director.
2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages.
American Association of Colleges of Pharmacy
The Health Roundtable CareTrack Australia Presenter: Natalie Hannaford Hospital Code Name: Innovation Poster Session HRT1215 – Innovation Awards Sydney.
Acute Quality Standards Dan Beckett Acute Physician CMO Advisor for Acute & General Medicine.
Is healthcare getting safer ? The challenge of measurement Charles Vincent Department of Psychology & Oxford Academic Health Science Network.
Increasing Pharmacists reporting of adverse medication incidents Being Ready for new risks and Opportunities Prepared by Tim Garrett Northern Sydney Central.
IMPLEMENTING GUIDELINES AND REDUCING PATIENT RISK OF VENOUS THROMBOEMBOLISM IN A LARGE UK TEACHING HOSPITAL Sharron Millen, Head of Clinical Pharmacy and.
How Much Does Medicare Pay Hospitals for Adverse Events? Building the Business Case for Investing in Patient Safety Improvement Chunliu Zhan, MD, PhD,
A Regional Approach to Improvement Julie Branter Associate Director for Clinical Governance and Patient Safety 21 September 2010 South West Strategic Health.
Risk assessment for VTE
The Role of Thromboprophylaxis in Elective Spinal Surgery The Role of Thromboprophylaxis in Elective Spinal Surgery VA Elwell, N Koo Ng, D Horner & D Peterson.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine,
© 2011 Blue Cross and Blue Shield of Minnesota. All rights reserved. The Role of Payment Reform in the Transformation of the HealthCare System Jim Eppel.
Specific Aim 1: Determine the impact of psychiatric disorders on the hospital length of stay (LOS) in pediatric patients diagnosed with SCD admitted for.
Harnessing Clinical Terminologies and Classifications for Healthcare Improvement Janice Watson Terminology Services Manager 11 th April 2013.
DVT Prevention and Anticoagulant Management
A Primary Care Trust Perspective NHS North Lancashire.
Venous Thromboembolism Prophylaxis for Medical Inpatients Heather Hofmann, rev. 4/18/14 DSR2 Mini Lecture.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine,
1 Patient safety indicators Yolanda Agra Varela. MD; Ph.D Sennior Adviser National Quality Agency. Ministry of Health Dublin 29 June 2006 Patient Safety.
Studying Health Care: Some ICD-10 Tools Hude Quan, Nicole Fehr, Leslie Roos University of Calgary and Manitoba Centre for Health Policy.
National Strategy for Quality Improvement in Health Care June 15, 2011 Kana Enomoto Director Office of Policy, Planning, and Innovation.
Risk assessment for VTE Dr Roopen Arya King’s College Hospital.
Focus Area 17: Medical Product Safety Progress Review November 5, 2003.
Australian Injury Indicators James Harrison Malinda Steenkamp Research Centre for Injury Studies, Flinders University of South Australia Incorporating.
The Latest Technology in the Hands of Experts Who Care.
Higher Incidence of Venous Thromboembolism (VTE) in the Outpatient versus Inpatient Setting Among Patients with Cancer in the United States Khorana A et.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, Pharmacy, CCE Confidential:
Confidential: Quality Improvement Material Reducing Clotting Events for Post-Surgical Orthopedic Patients Loyola Anticoagulation Clinic Spring 2009.
Older People’s Services The Single Assessment Process.
Airways - ICP launch Dr Mike Bewick Deputy Medical Director NHS England 17 Feb 2014.
Medicines Reconciliation A Whole System Approach Arlene Coulson Principal Clinical Pharmacist, Specialist Services Gordon Thomson Principal Clinical Pharmacist,
National Cancer Survivorship Initiative 2010 Update.
100 years of living science Chronic disease management in primary care: lessons to be learnt Dr Shamini Gnani November 2007, Mauritius.
Corporate slide master With guidelines for corporate presentations Dr Richard Lewis, National Professional Lead for Primary Care Early Reflections on Clusters.
Focus on health and care of mothers and infants ChiMat conference, 2009 Professor Mary Renfrew Mother and Infant Research Unit.
Dr Thomas Lloyd F1 Dr Aman Hargehandewal Wrexham Maelor Hospital
Department of Preventive Medicine Faculty of Public Health University of Debrecen General Practitioners’ Morbidity Sentinel Stations Program (GPMSSP) to.
Private and confidential Community Pharmacy Future Four-or-more medicines support service Update on progress and next steps Approved18 th June 2012 This.
Harm from Invasive Devices Dr. Eleri Davies, Faculty Lead HCAI.
Venous Thromboembolism Prophylaxis (VTE)
Outcomes from the Secondary Care COPD Audit 2014
Insert Objective 1 Insert Objective 2 Insert Objective 3.
Preventing VTE in hospitalised patients
Bruno Lucet – Stockholm october 30th 2016
Introducing 1000 Lives Plus
Cardiff and Vale UHB Dr Graham Shortland
Consultant Clinical Biochemist
Health Services that Deliver for Newborns Post-Doctoral Researcher
Presentation transcript:

VTE PREVENTION UPDATE, WA (May 2010) Dr Helen van Gessel Office of Safety and Quality Luke SlawomirskiPerformance Activity & Quality Division Delivering a Healthy WA

Safety and Quality Investment for Reform (SQuIRe) Program Since 2006/07 $8M each year across WA Health 8 quasi-collaboratives addressing priority clinical practice improvement areas –IHI “bundles”, process improvement focus –Central OSQ department “scaffolding” –Not voluntary –Area Health Services (x4) determine resource allocation and implementation

SQuIRe VTE prevention AIM –prevent VTE by performing risk assessment and correct prophylaxis (based on VTE Working Gp evidence summary – NB no formal state policy) PROCESSES TO MEASURE AND IMPROVE –% patients risk assessment –% patients at risk receiving correct prophylaxis Aligned with QUM indicator def n and sampling method Suggested initial focus surgical patients

Mid 2009 progress Estimated coverage 20% inpatients ; All hospitals have “VTE team”; Moves to sustainable process monitoring; Range of achievement

2010 aim – generate a “sense of urgency” Visit by NHS experts February 2010 Created WA VTE Prevention Network - 3 meetings, evolving interprofessional community of practice –“bring outside in” (Kotter) –Share ideas, experiences, learnings –Generate stories and new ideas –Generate data and talk about it in a meaningful way

Ideas progressing / testing NIMC risk assessment and mechanical prophylaxis prescription incorporation “signal” event investigation State VTE prevention policy State risk assessment tool Craft group – specific prophylaxis guidelines ?via Clinical Networks / professional Investigating value of coded data Talking to RFDS for country patient transfer diagnoses

Estimating Iatrogenic VTE Burden WA UK adult admissions; inpatient VTE in untreated pts; deaths/yr in untreated pts (UK Parliamentary Report) WA adult admissions; inpatient VTE in untreated pts; deaths/yr in untreated pts Est. 25 VTE untreated pts / 1000 separations

Iatrogenic VTE Incidence - Literature Gallagher et al (2009): 2.57 cases / 1000 CWS Leibson et al (2008): 2.59 / 1000 ‘encounters’ medicalcare/Abstract/2008/02000/Identifying_In_Hospital_Venous_Thromboembolism.5.aspx

VTE Incidence Data WA Request to Epidemiology Branch for 3 years’ VTE morbidity and mortality data ICD-10-AM codes (based Access Economics study 2008) COF (c-prefix) not used (WA: since July 2008) Aims: –Gauge extent of incidence and burden – ‘URGENCY’ –Validate VTE coding sensitivity & specificity (case note r/v, radiology, RFDS) –Calculate extended LOS and additional cost of VTE

Codes (preliminary list) WA DoH RequestAccess Economics Study 2008 I26 pulmonary Embolism I26.0 pulmonary Embolism with mention of acute cor pulmonale I26.8 iatrogenic pulmonary embolism I26.9 pulmonary Embolism without mention of acute cor pulmonale I63.1 cerebral infarction due to embolism of pre-cerebral arteries I63.4 cerebral infarction due to embolism of cerebral arteries I74 arterial embolism and thrombosis I80.2 deep vein thrombosis not otherwise specified I80.3 embolism or thrombosis of lower extremity I82.2 embolism and thrombosis of vena cava I82.3 embolism and thrombosis of renal vein I82.8 embolism and thrombosis of other specified veins I82.9 embolism and thrombosis of unspecified vein I26 pulmonary Embolism I26.0 pulmonary Embolism with mention of acute cor pulmonale I26.8 iatrogenic pulmonary embolism I26.9 pulmonary Embolism without mention of acute cor pulmonale I63.1 cerebral infarction due to embolism of pre-cerebral arteries I63.4 cerebral infarction due to embolism of cerebral arteries I74 arterial embolism and thrombosis I82 other venous embolism and thrombosis I82.2 embolism and thrombosis of vena cava I82.3 embolism and thrombosis of renal vein I82.8 embolism and thrombosis of other specified veins I82.9 embolism and thrombosis of unspecified vein

Preliminary Administrative Data Extract WA Area Health Service; July 2009 – March 2010 Total separations ~ 147,000 ICD-10-AM codes from prev. slide COF* 1 & 2 = 832 cases (5.6 per 1000 separations) Est. 50% healthcare associated = 416 (2.8 / 1000 seps) COF 1 only = 107 cases * see next 2 slides for definitions

Condition onset Flag (COF) COF 1 Condition with onset during the episode of admitted patient care a condition which arises during the episode of admitted patient care and would not have been present on admission Includes: –Conditions resulting from misadventure during medical or surgical care during the episode of admitted patient care. –Abnormal reactions to, or later complication of, surgical or medical care arising during the episode of admitted patient care. –Conditions arising during the episode of admitted patient care not related to surgical or medical care (for example, pneumonia).

COF 2 Condition not noted as arising during the episode of admitted patient care a condition present on admission such as the presenting problem, a comorbidity, chronic disease or disease status. a previously existing condition not diagnosed until the episode of admitted patient care. Includes: –In the case of neonates, the conditions present at birth. –A previously existing condition that is exacerbated during the episode of admitted patient care. –Conditions that are suspected at the time of admission and subsequently confirmed during the episode of admitted patient care. –Conditions that were not diagnosed at the time of admission but clearly did not develop after admission (for example malignant neoplasm). –Conditions where the onset relative to the beginning of the episode of admitted patient care is unclear or unknown.

COF 1 & 2 dataset (n=832)

Follow-up work to assess utility of admin data sources Larger data set pending Case note review validation –Sample of code – positive and code-negative records

COF 1 dataset (n=107)